Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04614753 · ClinicalTrials.gov registry record · NA
Dealcoholized Muscadine Wine and Skin Health in Women
A NA study, sponsored by University of Florida.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT04614753 is a NA study that has completed, run by University of Florida. The registered enrollment target is 20 participants.
The verdict
NCT04614753, a NA study, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
The objective of this clinical trial is to determine the activity of dealcoholized muscadine wine to alleviate oxidative stress, inflammation, skin photoaging, and alter gut microbiome in women 40-67 years of age. The investigators hypothesize that dealcoholized muscadine wine daily for 42 days will significantly alleviate oxidative stress, inflammation, skin photoaging, and alter the gut microbiome in women compared to drinking sugar water.
Interventions
- OTHER Control Beverage
- OTHER Dealcoholized Muscadine Wine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2020-10-10 |
| Est. Completion | 2024-10-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04614753
The ClinicalTrials.gov registry entry for NCT04614753 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Control Beverage is the first listed.
NCT04614753 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04614753 about?
NCT04614753 is a clinical study titled "Dealcoholized Muscadine Wine and Skin Health in Women". The objective of this clinical trial is to determine the activity of dealcoholized muscadine wine to alleviate oxidative stress, inflammation, skin photoaging, and alter gut microbiome in women 40-67 years of age. The investigators hypothesize that dealcoholized muscadine wine daily for 42 days will...
What is the current status of trial NCT04614753?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2020-10-10. Estimated completion is 2024-10-07.
What interventions are being tested in trial NCT04614753?
The interventions under investigation include: Control Beverage (OTHER), Dealcoholized Muscadine Wine (OTHER).
Who is sponsoring clinical trial NCT04614753?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.